HtmlToText
search search menu menu home teams staff full listing team 1: cardiovascular immunobiology team 2: cardiovascular structural diseases team 3: cardiovascular bioengineering team 4: cardiovascular imaging team 5: atherothrombotic disease in heart and brain team 6: hemostasis, thrombo-inflammation and neurovascular repair secretary & common services organogram our partners platforms recent articles visit extrasections didactic materials journal club lvts videos skip to content menu menu home teams staff full listing team 1: cardiovascular immunobiology team 2: cardiovascular structural diseases team 3: cardiovascular bioengineering team 4: cardiovascular imaging team 5: atherothrombotic disease in heart and brain team 6: hemostasis, thrombo-inflammation and neurovascular repair secretary & common services organogram our partners platforms recent articles visit extrasections didactic materials journal club lvts videos home overview the general objectives of the lvts umrs1148 are the understanding of the physiological mechanisms by basic science approaches but also through large clinical trials, development of new diagnostic (markers and imaging) and new therapeutic/biomaterial strategies : identification of new targets, development of new molecules, validated by clinical trials. to carry out these projects, translational human and technological skills include clinical databases and assays, translational clinical investigations (carotid stenosis, aneurysms and dissections of the ascending aorta, biocore), human tissue and cell biobanks, numerous experimental models of disease (transgenic mice, rats, rabbits), new methods in molecular and cell biology (proteomics, genetics & epigenetics, protein engineering, flow cytometry), chemistry of biopolymers, elaboration of biomaterials and nanosystems, and imaging technologies in small animals and in humans (nuclear imaging, ultrasound and mri). the unit is organised into 6 collaborative teams affiliated to 3 different itmo (national institutes) pmn, technologies for health, genetics, and to 2 inserm scientific sections (css3 and css6). the teams are hosted in 3 locations in the north of paris: -in the inserm building at the xavier bichat hospital ( ufr de médecine ; paris 7 university) -at the ufr santé médecine et biologie humaine (bobigny; paris 13 university) -at the institut galilée (villetaneuse, paris 13 university) team 1: cardiovascular immunobiology team 2: cardiovascular structural diseases team 3: cardiovascular bioengineering team 4: cardiovascular imaging team 5: atherothrombotic disease in heart and brain team 6: hemostasis, thrombo-inflammation and neurovascular repair secretary & common services a la une catherine boileau awarded the “grand prix lefoulon-delalande 2018” catherine boileau (team 2) was awarded, together with helen hobbs (university of texas southwestern medical school, dallas – etats-unis) and nabil seidah (institut de recherches cliniques de montréal – canada), the grand prix de la fondation lefoulon delalande during a … jun 10, 2018 mooc: tissue and organ bioengineering marie-noëlle labour (team 3) is actively involved in the mooc “tissue and organ bioengineering”. you can freely attend and register to this mooc until 8th june 2018. it will be broadcasted between the 14 may and 17 june 2018. link to feb 28, 2018 ethique et intégrité scientifiques jan 17, 2018 improved prognosis in nstemi patients a recent publication from team 5 has been released in circulation demonstrates that patients with high risk non–st-segment–elevation myocardial infarction (nstemi) that undergo coronary angiography within the initial 12 hours after admission had a lower risk of ischemic outcomes at 180 days. timing of … jan 1, 2018 dominique le guludec appointed head of the haute autorité de santé dominique le guludec, professor of biophysics and nuclear medicine at the ufr of medicine at paris diderot university, director of the department of nuclear medicine and biophysics at bichat hospital – claude bernard, aphp and head of the imaging team … dec 13, 2017 acticor biotech first-in-human clinical trial in healthy volunteers acticor biotech, a clinical stage biotechnology company (raised on the basis of a work initiated in team 6 of u1148) involved in the acute phase of thrombotic diseases, including stroke and myocardial infarction, today announced the agreement of dutch authorities … oct 18, 2017 interview of dr. catherine boileau at the esc 2017 after her william harvey lecture award dr. catherine boileau (team 2) talks with dr. niels voigt for cardiovascular research onlife at the 2017 william harvey lecture of the european society of cardiology. watch the interview: sep 25, 2017 tf1 talks about fucoidans cedric chauvierre (team 3) has given an interview on the use of fucoidans to trace early atherothrombotic lesions for the tv news on the first french channel (tf1) on the 14th august 2017. you can see it here: aug 16, 2017 d letourneur granted the 2017 asian polymer association (apa)’s jubilee award didier letourneur (director of lvts, head of team 3) has been awarded the 2017 asian polymer association (apa)’s jubilee award. apa was founded in 2007 at the premises of indian institute of technology, new delhi, india, www.asianpolymer.org. the society involves academicians, … may 8, 2017 prof g jondeau, coordinator of vascern prof guillaume jondeau (team 2) is the corrdinator of vascern, the european reference network on rare multisystemic vascular diseases. “the vascern project aims to facilitate and improve diagnosis, treatment and care for all patients suffering from rare multisystemic vascular diseases, thus enhancing … apr 21, 2017 signature of the save-brain and survi msd-avenir projects on the 18th april 2017, d blazy (président du conseil scientifique de msd-avenir) on the behalf of c schiever (président du ca de msd-avenir), m hirsch (directeur général de l’ap-hp), the prof y levy (président directeur général de l’inserm), in the … apr 19, 2017 announce: the rhu ivasc web site is open! you are invited to visit the brand new web site of the ivasc rhu. spread the voice around you! our unit is critically involved in this clinical research program and several u1148’s pi are wp leader of the rhu ivasc. visit the … mar 22, 2017 rhu call results: lvts involved in 5 granted projects! the ‘rhu’ (recherche hospital universitaire) action is to support translational research projects in health or clinical research, which are to be based on fundamental research in biology, epidemiology, social science or health economics and extend for a benefit for the care of … jul 1, 2016 early detection of strokes télématin broadcasted on the 13rd may 2016 an interview from prof pierre amarenco (team 5) where it is explained why we should detect stroke as soon as possible. this is related to a paper published this year by p amarenco et … may 13, 2016 acticor, a biotech supported by crowdfunding – france 5 the ‘magazine de la santé’ on france 5 has taken the example of acticor, a startup based in u1148, for the emerging supports of biotech development through crowdfunding. you can watch the program here (broadcasted on the jan 28, 2016 jean-baptiste michel granted the ‘grand prix lamonica’ from the ‘académie des sciences’ on the 24th november 2015, jean-baptiste michel received the ‘grand prix lamonica’ from the ‘académie des sciences’. you can watch an extract of the ceremony here, or the full ceremony nov 27, 2015 jb michel, granted a prize from académie des sciences 2015 the ‘académie des sciences’ grants 5 main prizes and 4 thematic ones to inserm researchers. this year, jean-baptiste michel, a researcher of lvts team 1, has been granted the ‘grand prix lamonica de cardiologie. download the full sep 27, 2015 prof. d le guludec appointed chairperson of the board of directors of irsn phd in biophysics, dominique le guludec is professor of biophysics and nuclear medicine at university paris 7. she is
lvts.fr rapport :
Visitez le site